Aventura Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
Aventura Private Wealth's XBI Position: Q2 2026 in Review
Aventura Private Wealth increased its State Street SPDR S&P Biotech ETF (XBI) stake by 207% in Q2 2026, buying an estimated $28K and bringing the position to 307 shares worth $48.6K. The position accounts for 0.01% of the portfolio, ranked #351.
Aventura Private Wealth first reported a position in XBI in Q1 2026 and has held it in 2 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Aventura Private Wealth held 307 shares of State Street SPDR S&P Biotech ETF worth $48.6K as of Q2 2026.
- Aventura Private Wealth bought 207 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $28K.
- State Street SPDR S&P Biotech ETF made up 0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #351 holding.
- Aventura Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 2 quarters since.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.